WID Researchers Collaborate on UW2020 Projects
Researchers at the Wisconsin Institute for Discovery are co-Principal Investigators and co-Investigators on four UW2020: WARF Discovery Initiative projects.
Tag: cancer
WID researchers are engaged in cancer research from many different perspectives, including precision medicine, immunotherapy development, epigenic inquiry, and several omics-related angles. With a focus on Healthy People, WID is committed to working with its campus partners to understand and treat cancer more effectively.
How Mutations in Cell DNA Can Lead to Cancer
Peter Lewis and his research group at WID study how mutations in DNA-organizing histone proteins lead to cancer development.
WID Researchers Looking to the Future with UW2020 Awards
Investigators from WID are among the recipients of the latest round of UW2020 awards.
UW Carbone Scientists Present at Annual Cancer Research Conference
One of the UW Carbone Cancer Center members presenting is WID’s Peter Lewis. His work focuses on how genes are turned on and off during embryonic development, and how misregulation in those genes can lead to some childhood cancers.
WID Researchers Receive Awards to Fund Cancer Research
Mark Klein and Peter Lewis were recognized for their cancer research awards from The Ride, sponsored by the UW Carbone Cancer Center, at a recent Wisconsin Men’s Hockey game.
UW-Madison to be Partner in Center for Cell Manufacturing Technologies
The National Science Foundation has awarded nearly $20 million to a consortium of universities to support a new engineering research center that will develop transformative tools and technologies for the consistent, scalable, and low-cost production of high-quality living therapeutic cells. Several WID investigators are collaborators on the project.
Saha Human Stem Cell Engineering Lab
By bringing together stem cell biology, genome engineering, and biomaterials expertise, the Saha lab generates new tools for use with human-induced pluripotent stem cells to ask unique questions about human biology and disease.
Ashton Group: Stem Cell Bioprocessing and Regenerative Biomaterials Lab
The Ashton Group is working to understand, model, and recapitulate in vitro the instructive signals utilized by human embryos to pattern tissue-specific differentiation of pluripotent stem cells, and apply this knowledge towards the rational design of tissue engineered scaffolds and other regenerative therapeutic strategies.
Multi-Omics Hub
The Multi-Omics Hub will focus on the use of big data about the genes, microorganisms, and metabolites to understand biological systems. WID’s expertise makes it an ideal home for the Epigenetics Initiative for the large campus community that studies the epigenome, and as such WID will organize meetings, seminars, mutli-PI …
Smart Cancer Therapies: Teaching the Body’s Own T-cells to Attack Tumors
Kris Saha with colleagues David Beebe and Christian Capitini aim to develop improved methods for making CAR T-Cells with a two-year grant from the NSF.
Gene Regulatory Mutation Linked to Rare Childhood Cancer
Epigenetics researcher Peter Lewis has linked a histone mutation to a rare pediatric bone cancer, an important step in understanding and treating more common cancers.
Mass Spectrometry Brings Epigenetics into Focus at UW
The Epigenetics theme at WID is putting mass spectrometry to use in new ways with specialized workflows designed to uncover the mysteries of chromatin.
Peter Lewis Explores the Epigenetic Pathways of Disease
Short circuiting tumors via Epigenetics drives Lewis Lab’s research.
Beyond genetics: Ideas from a flowering plant
Xuehua Zhong, Assistant Professor in WID’s Epigenetics Theme studies the epigenetic connections mammals share with plants.
With New Tools, Researchers Aim to Broaden Understanding of Toxins’ Effect on the Body
Through an Environmental Protection Agency initiative, WID researchers are playing a key role in learning how toxins impact human health and the environment.
Flipping the Switch on Pluripotent Stem Cells
Rupa Sridharan, Assistant Professor of Cell and Regenerative Biology at Wisconsin Institute for Discovery explains how she increased reprogramming efficiency to get pluripotent stem cells.